Sort
21,453 grants matching “tuberculosis”
Ph2a Study: Rifampin, Merrem, Augmentin for Tuberculosis IND 129159; 12/31/2015
$499,958Kelly E. Dooley · Johns Hopkins University · R01 · FY2018 · FD
Ph2a Study: Rifampin, Merrem, Augmentin for Tuberculosis IND 129159; 12/31/2015
$499,957Kelly E. Dooley · Johns Hopkins University · R01 · FY2019 · FD
Improving specificity of HPV Screen-and-Treat in South Africa
$499,947Louise Kuhn · Columbia University Health Sciences · UH2 · FY2014 · CA
Regulation of Salmonella Virulence bythe PhoP Protein
$499,927Eduardo A. Groisman · Yale University · R01 · FY2019 · AI
Structure, Function and Applications of Inteins
$499,893Tom W Muir · Rockefeller University · R01 · FY2008 · GM
Implementation/Evaluation of TB, HIV, and Syphilis Screening in Ethiopian Prisons
$499,881Wondwossen Amogne Degu · Ethiopian Public Health Association · U01 · FY2013 · GH
The CryptoART Study: Decreasing mortality associated with initiation of antiretro
$499,816Chiratidzo Ellen Ndhlovu · College Of Health Scis Univ Of Zimbabwe · U01 · FY2013 · GH
TRI-PARTITE COLLABORATIVE: TARGETED GENOME EDITING TO UNDERSTAND AND ENHANCE GENETIC RESISTANCE TO BOVINE TUBERCULOSIS IN DOMESTIC CATTLE POPULATIONS (TARGET-TB)
$499,700Recombinetics Inc · · FY2018 · National Institute of Food and Agriculture
Drug Development for MDR-M tuberculosis
$499,659Johns Hopkins University · U01 · FY2003 · AI
TUBERCULOSIS GENOTYPING AND EVOLUTIONARY CONSORTIUM
$499,628Univ Of Med/Dent Of Nj-Nj Medical School · R01 · FY2005 · AI
Evaluation of National Video Directly Observed Therapy Implementation
$499,597Sebastian Seiguer · Emocha Mobile Health, Inc. · R44 · FY2018 · MD
Mycobacterial Proteasome Inhibitors
$499,576Carl F Nathan · Weill Medical Coll Of Cornell Univ · R56 · FY2010 · AI
Intelligent Imaging Spinning Disk Confocal Microscope
$499,532David W Raible · University Of Washington · S10 · FY2010 · RR
Human macrophage variation & TB pathogenesis
$499,471Thomas R Hawn · University Of Washington · U19 · FY2022 · AI
Regulation of Salmonella Virulence bythe PhoP Protein
$499,433Eduardo A. Groisman · Yale University · R01 · FY2016 · AI
Microbiome in TB treatment response and disease resolution
$499,379Sabine Ehrt · Weill Medical Coll Of Cornell Univ · U19 · FY2022 · AI
Protein/Lipid Interactions
$499,329Robert B. Gennis · University Of Illinois At Urbana-Champaign · R01 · FY2013 · HL
Mycobacterial Proteasome Inhibitors
$499,329Carl F Nathan · Weill Medical Coll Of Cornell Univ · R56 · FY2009 · AI
TUBERCULOSIS PREVENTION AND CONTROL COOPERATIVE AGREEMENT
$499,300Sherry Ketemepi · Baltimore City Health Department · U52 · FY2010 · PS
Optimal targeting for individual and population-level TB prevention
$499,215Nicolas A Menzies · Harvard School Of Public Health · R01 · FY2023 · AI
Optimal targeting for individual and population-level TB prevention
$499,215Nicolas A Menzies · Harvard School Of Public Health · R01 · FY2022 · AI
BSL-3 Practices Core
$499,204Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2025 · AI
Mycobacterial Sulfation Pathways
$499,188Carolyn R Bertozzi · University Of California Berkeley · R01 · FY2010 · AI
Southeast Regional Centers of Excellence for Biodefense & Emerging Infectious Di
$499,170Philip Frederick Sparling · Univ Of North Carolina Chapel Hill · U54 · FY2010 · AI
Tulane/LSU HIV/AIDS Clinical Trials Networks Unit
$499,167Russell Barrett Van Dyke · Tulane University Of Louisiana · U01 · FY2007 · AI